The fund aims to back both Chinese startups with the legs for global markets and companies outside China with products that could succeed there, according to the China Money Network.
Suzhou-BioBay, a life sciences incubator, also joined the Medtronic-Sequoia China Healthcare Technology Venture Investment Fund as a limited partner, according to the website.
“This fund is Medtronic’s 1st early-stage investment vehicle established outside of our home country,” CEO Omar Ishrak said, according to CMN. “Our hope is to support innovation to meet the increasing demand in China’s healthcare market.”
On June 4-5, DeviceTalks Minnesota is taking over the Twin Cities medtech industry with one of the most anticipated conferences of the spring.
Join leaders from 3M, Abbott, Bigfoot Biomedical, Boston Scientific, Cardionomic, CMF Solutions, Cyient, Google Mayo Clinic, Medical Alley, Medtronic, NxThera, Opus College, Relievant Medsystems, University of Minnesota, Star Tribune, Smith & Nephew, Spry Health, Zimmer Biomet and many more when you register today.
Use the code "DTWeb" to save 15% on the cost of registration.